BINDING OF FACTOR-VIIIA AND FACTOR-VIII TO FACTOR-IXA ON PHOSPHOLIPID-VESICLES

被引:0
作者
DUFFY, EJ
PARKER, ET
MUTUCUMARANA, VP
JOHNSON, AE
LOLLAR, P
机构
[1] EMORY UNIV,DEPT MED,DIV HEMATOL ONCOL,DRAWER AJ,1003 WOODRUFF MEM BLDG,ATLANTA,GA 30322
[2] UNIV OKLAHOMA,DEPT CHEM & BIOCHEM,NORMAN,OK 73019
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activation of factor X by factor IXa (fIXa) in the presence of phosphatidylcholine-phosphatidylserine (PCPS) vesicles is markedly accelerated by thrombin-activated factor VIII (fVIIIa). The interaction between highly purified fVIIIa and fIXa in this complex was studied fluorometrically at 25-degrees-C by using a derivative of D-phenylalanyl-prolyl-arginyl-fIXa which was modified at the active site with fluorescein-5-maleimide (Fl-M-FPR-fIXa). Titration of Fl-M-FPR-fIXa with fVIIIa at fixed PCPS resulted in a large, saturable increase in anisotropy (DELTA-r = 0.09). The titration data were fit to a model assuming a reversible equilibrium between fVIIIa and fIXa, resulting in an apparent dissociation constant of 2 nM and a stoichiometry of 1 mol of fVIIIa/mol of Fl-M-FPR-fIXa. The initial velocity of factor X activation was measured under identical conditions except that active fIXa and factor X were included, which yielded binding parameters similar to those determined fluorometrically. Thus, the fluorescence method accurately reflects complex formation between fVIIIa and fIXa on the phospholipid surface, and the fVIIIa-fIXa interaction is not influenced by the presence of the substrate, factor X. Addition of fVIII to Fl-M-FPR-fIXa and PCPS produced a small, saturable increase in anisotropy (DELTA-r = 0.03), followed by a larger increase (DELTA-r = 0.07) upon addition of thrombin to activate fVIII. Thus, fVIII binds fIXa, but proteolytic modification of fVIII must occur before the complete fVIIIa-dependent structural change in the active site of fIXa, as reflected in the anisotropy change, occurs.
引用
收藏
页码:17006 / 17011
页数:6
相关论文
共 53 条
[1]   INTERACTION OF FACTOR-VIII-VONWILLEBRAND FACTOR WITH PHOSPHOLIPID-VESICLES [J].
ANDERSSON, LO ;
BROWN, JE .
BIOCHEMICAL JOURNAL, 1981, 200 (01) :161-167
[2]   ISOLATION AND CHARACTERIZATION OF HUMAN FACTOR-VIII - MOLECULAR-FORMS IN COMMERCIAL FACTOR-VIII CONCENTRATE, CRYOPRECIPITATE, AND PLASMA [J].
ANDERSSON, LO ;
FORSMAN, N ;
HUANG, K ;
LARSEN, K ;
LUNDIN, A ;
PAVLU, B ;
SANDBERG, H ;
SEWERIN, K ;
SMART, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (09) :2979-2983
[3]   SIMPLE METHOD FOR PREPARATION OF HOMOGENEOUS PHOSPHOLIPID VESICLES [J].
BARENHOLZ, Y ;
GIBBES, D ;
LITMAN, BJ ;
GOLL, J ;
THOMPSON, TE ;
CARLSON, FD .
BIOCHEMISTRY, 1977, 16 (12) :2806-2810
[4]  
Bevington P.R., 1969, DATA REDUCTION ERROR
[6]  
CHASE T, 1970, METHOD ENZYMOL, V19, P20
[7]   COAGULATION FACTOR-V AND FACTOR-VIII AND CERULOPLASMIN CONSTITUTE A FAMILY OF STRUCTURALLY RELATED PROTEINS [J].
CHURCH, WR ;
JERNIGAN, RL ;
TOOLE, J ;
HEWICK, RM ;
KNOPF, J ;
KNUTSON, GJ ;
NESHEIM, ME ;
MANN, KG ;
FASS, DN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (22) :6934-6937
[8]   EFFECTS OF THROMBIN TREATMENT ON PREPARATIONS OF FACTOR-8 AND CA2+-DISSOCIATED SMALL ACTIVE FRAGMENT [J].
COOPER, HA ;
REISNER, FF ;
HALL, M ;
WAGNER, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (03) :751-760
[9]  
DAVIE EW, 1987, HEMOSTASIS THROMBOSI, P242
[10]  
DUFFY EJ, 1992, J BIOL CHEM, V267, P7821